Citigroup’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,190
| Closed | -$21K | – | 5201 |
|
|
2018
Q3 | $21K | Buy |
+1,190
| New | +$21K | ﹤0.01% | 4506 |
|
|
2018
Q2 | – | Sell |
-288
| Closed | -$3K | – | 5177 |
|
|
2018
Q1 | $3K | Sell |
288
-1,225
| -81% | -$12.8K | ﹤0.01% | 4730 |
|
|
2017
Q4 | $6K | Buy |
+1,513
| New | +$6K | ﹤0.01% | 4642 |
|
|
2017
Q2 | – | Sell |
-304
| Closed | -$1K | – | 5079 |
|
|
2017
Q1 | $1K | Sell |
304
-37,941
| -99% | -$125K | ﹤0.01% | 4773 |
|
|
2016
Q4 | $98K | Buy |
38,245
+27,653
| +261% | +$70.9K | ﹤0.01% | 3912 |
|
|
2016
Q3 | $33K | Buy |
10,592
+1,079
| +11% | +$3.36K | ﹤0.01% | 3943 |
|
|
2016
Q2 | $30K | Sell |
9,513
-27,312
| -74% | -$86.1K | ﹤0.01% | 3977 |
|
|
2016
Q1 | $114K | Buy |
36,825
+17,843
| +94% | +$55.2K | ﹤0.01% | 3873 |
|
|
2015
Q4 | $76K | Buy |
18,982
+17,545
| +1,221% | +$70.2K | ﹤0.01% | 3782 |
|
|
2015
Q3 | $7K | Sell |
1,437
-16,983
| -92% | -$82.7K | ﹤0.01% | 4545 |
|
|
2015
Q2 | $96K | Buy |
18,420
+8,984
| +95% | +$46.8K | ﹤0.01% | 3280 |
|
|
2015
Q1 | $59K | Sell |
9,436
-6,908
| -42% | -$43.2K | ﹤0.01% | 3796 |
|
|
2014
Q4 | $103K | Buy |
16,344
+12,168
| +291% | +$76.7K | ﹤0.01% | 3630 |
|
|
2014
Q3 | $25K | Buy |
4,176
+3,863
| +1,234% | +$23.1K | ﹤0.01% | 4132 |
|
|
2014
Q2 | $2K | Sell |
313
-27,594
| -99% | -$176K | ﹤0.01% | 5180 |
|
|
2014
Q1 | $665K | Buy |
27,907
+467
| +2% | +$11.1K | ﹤0.01% | 1879 |
|
|
2013
Q4 | $293K | Buy |
27,440
+6,370
| +30% | +$68K | ﹤0.01% | 2811 |
|
|
2013
Q3 | $281K | Buy |
21,070
+2,684
| +15% | +$35.8K | ﹤0.01% | 2353 |
|
|
2013
Q2 | $241K | Buy |
+18,386
| New | +$241K | ﹤0.01% | 2591 |
|